Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease.

OBJECTIVES The objectives of this study were to test prospectively for an association between Chlamydia and atherosclerosis by comparing the incidence of the pathogen found within atherosclerotic plaques in patients undergoing directional coronary atherectomy with a variety of control specimens and comparing the clinical features between the groups. BACKGROUND Previous work has suggested an association between Chlamydia pneumoniae infection and coronary atherosclerosis, based on the demonstration of increased serologic titers and the detection of bacteria within atherosclerotic tissue, but this association has not yet been regarded as established. METHODS Coronary specimens from 90 symptomatic patients undergoing coronary atherectomy were tested for the presence of Chlamydia species using direct immunofluorescence. Control specimens from 24 subjects without atherosclerosis (12 normal coronary specimens and 12 coronary specimens from cardiac transplant recipients with subsequent transplant-induced coronary disease) were also examined. RESULTS Coronary atherectomy specimens were definitely positive in 66 (73%) and equivocally positive in 5 (6%), resulting in 79% of specimens showing evidence for the presence of Chlamydia species within the atherosclerotic tissue. In contrast, only 1 (4%) of 24 nonatherosclerotic coronary specimens showed any evidence of Chlamydia. The statistical significance of this difference is a p value < 0.001. Transmission electron microscopy was used to confirm the presence of appropriate organisms in three of five positive specimens. No clinical factors except the presence of a primary nonrestenotic lesion (odds ratio 3.0, p = 0.057) predicted the presence of Chlamydia. CONCLUSIONS This high incidence of Chlamydia only in coronary arteries diseased by atherosclerosis suggests an etiologic role for Chlamydia infection in the development of coronary atherosclerosis that should be further studied.

[1]  G. Rodgers,et al.  Chlamydia species infect human vascular endothelial cells and induce procoagulant activity. , 1997, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[2]  D. Siscovick,et al.  Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. , 1992, JAMA.

[3]  H. Fukushi,et al.  Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. , 1993, The Journal of infectious diseases.

[4]  W. Peterson,et al.  Helicobacter pylori and peptic ulcer disease. , 1991, The Western journal of medicine.

[5]  M. Leinonen.  Pathogenetic mechanisms and epidemiology of Chlamydia pneumoniae. , 1993, European heart journal.

[6]  M. Nieminen,et al.  SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTION , 1988, The Lancet.

[7]  N. Edvardsson.  Comparison of class I and class III action in atrial fibrillation. , 1993, European heart journal.

[8]  Y. Goo,et al.  Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[9]  P. Saikku,et al.  A NEW RESPIRATORY TRACT PATHOGEN: CHLAMYDIA PNEUMONIAE STRAIN TWAR , 1990, The Journal of infectious diseases.

[10]  J. Kosek,et al.  Experiences in heart transplantation. Technic, physiology and rejection. , 1968, The American journal of cardiology.

[11]  P. Saikku,et al.  The epidemiology and significance of Chlamydia pneumoniae. , 1992, The Journal of infection.

[12]  P. Ernsberger,et al.  The I1‐imidazoline receptor: from binding site to therapeutic target in cardiovascular disease , 1997, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[13]  D. Patton,et al.  Ultrastructural lung pathology of experimental Chlamydia pneumoniae pneumonitis in mice. , 1994, The Journal of infectious diseases.

[14]  A. Coulson,et al.  Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. , 1995, Circulation.

[15]  M. Leinonen,et al.  Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study , 1992, Annals of Internal Medicine.

[16]  Moxon Er.  Microbes, molecules and man. The Mitchell Lecture 1992. , 1993 .

[17]  R. Wissler.  Update on the pathogenesis of atherosclerosis. , 1991, The American journal of medicine.

[18]  M. Topham,et al.  Inflammatory roles of P-selectin. , 1993, The Journal of clinical investigation.

[19]  R D Safian,et al.  Coronary atherectomy. Clinical, angiographic, and histological findings and observations regarding potential mechanisms. , 1990, Circulation.

[20]  R. Ross,et al.  Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. , 1993, British heart journal.

[21]  G. Steinbeck,et al.  Temperature-controlled radiofrequency catheter ablation of AV conduction: first clinical experience. , 1993, European heart journal.

[22]  R. Kronmal,et al.  Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[23]  M. Nieminen,et al.  Chlamydia Pneumoniae‐Specific Circulating Immune Complexes in Patients With Chronic Coronary Heart Disease , 1993, Circulation.

[24]  P. Saikku.  Chlamydia pneumoniae infection as a risk factor in acute myocardial infarction. , 1993, European heart journal.